At the news
? MIXEDIMPACT 5/10 COURT-RULING filed Aug 18, 2026 at 20:00 ET
Collegium Pharmaceutical won partial dismissal of Walgreens' breach-of-contract lawsuit in Massachusetts federal court. The court dismissed Walgreens' breach of contract and implied covenant claims (Counts I and II) with prejudice, finding no contractual relationship existed between the parties. However, Walgreens' unjust enrichment claim (Count IV) and Massachusetts Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss, with Walgreens seeking $14.3 million in damages for allegedly delayed product returns. The case proceeds on these two claims, creating ongoing litigation risk but removing the most direct contractual liability exposure.
- Court dismissed breach of contract (Count I) and implied covenant (Count II) claims against Collegium, finding no enforceable contract existed between Walgreens and Collegium.
- Walgreens' unjust enrichment claim (Count IV) survived, alleging Collegium retained $14,321,229.99 in value from products Walgreens could not return due to delayed Form 222 authorizations.
- Walgreens' Chapter 93A unfair/deceptive trade practices claim (Count III) survived the motion to dismiss.
- The case was originally filed in June 2025 in Illinois, dismissed for lack of personal jurisdiction in February 2026, and refiled in Massachusetts in March 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access